Oxford Laboratories Pvt. Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Oxford Laboratories Pvt. Ltd. - overview
Established
2000
Location
Mumbai, Maharashtra, India
Primary Industry
Consumer Products
About
Oxford Laboratories Pvt. Ltd. excels in developing and manufacturing healthcare products, focusing on pharmaceuticals, nutraceuticals, and herbal-cosmetics, serving diverse medical needs across several international markets. Founded in 2000, Oxford Laboratories Pvt.
Ltd. is based in Mumbai, India. The company specializes in healthcare solutions, evolving its product line over the years to include various delivery forms tailored to market demands. The founder’s history and previous ventures are not detailed in the available information.
Oxford Laboratories specializes in developing and manufacturing a comprehensive range of healthcare products, including pharmaceuticals, nutraceuticals, and herbal-cosmetic formulations. Their product offerings feature various delivery methods such as tablets, capsules, injectables, and oral suspensions, aiming to address a wide array of medical needs. They focus on effective treatments and overall wellness, also promoting beauty through cosmetic products. Their market presence spans Asia, CIS countries, Africa, and Latin America, providing high-quality healthcare solutions through rigorous quality assurance processes in WHO-GMP certified facilities.
In 2023, Oxford Laboratories reported a revenue of USD 5. 21 mn and an EBITDA of USD 1. 51 mn. The company generates revenue through direct transactions with healthcare providers, wholesalers, and retailers, primarily through B2B sales and partnerships in the pharmaceutical and healthcare sectors.
Their pricing model aligns product categories with market demand, contributing significantly to overall sales, particularly in established and emerging markets. The company's future growth strategy focuses on launching new products in the upcoming fiscal year, aiming to meet the evolving healthcare needs of various markets. Additionally, Oxford Laboratories plans to expand into new regions, specifically targeting markets in North Africa and Southeast Asia by 2025. Recent funding will be utilized to bolster product development and enhance distribution capabilities in these regions, aiming to solidify their market position.
Primary Industry
Consumer Products
Sub Industries
Consumer Products, Logistics & Distribution
Website
www.oxfordlab.com
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.